Ikena Oncology, Inc.IKNANASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P29
Within normal range
vs 2Y Ago
-7.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-6.42%
202427.77%
20230.87%
2022-101.57%
202122.91%
2020-163.16%
201958.85%
20180.00%